Dorzolamide Hydrochloride
Product Images NDC 70377-081

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Dorzolamide Hydrochloride (NDC 70377-081). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Biocon Pharma Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

124 (Dorzola Fig 1)

An instructional illustration labeled Fig. A showing a bottle with a cap and a tear-off tamper evident ring. The diagram points to and identifies the cap, bottle, and tamper evident ring components.*

FDA Label Image

124 (Dorzola Fig 2)

An instructional line drawing depicting a hand holding a bottle with a dropper tip, with another hand rotating the collar or cap near the top of the bottle, labeled as Figure B.*

FDA Label Image

125 (Dorzola Fig 3)

An instructional illustration showing a person using their hands to twist and remove the cap of a bottle, likely representing the opening method for a product container. The figure is labeled as Fig. C.*

FDA Label Image

126 (Dorzola Fig 4)

An instructional illustration showing a person applying eye drops. The person tilts their head back and uses one hand to pull down the lower eyelid while the other hand positions the eye drop bottle above the eye.*

FDA Label Image

127 (Dorzola Fig 5)

An instructional line drawing depicting a person administering eye drops. The individual uses one hand to pull down the lower eyelid and holds a dropper bottle above the eye with the other hand to apply the medication.*

FDA Label Image

Dorzolamide-carton (Dorzolamide Carton)

Packaging label for Dorzolamide Hydrochloride ophthalmic solution, USP 2% sterile eye drops, 10 mL, labeled by Biocon Pharma Inc. The label includes dosage strength, active ingredient concentration (22.3 mg/mL dorzolamide HCl equivalent), usage instructions emphasizing for ocular use only, and storage guidance. The label also shows the product NDC 70377-081-11, barcodes, manufacturer details, and lot and expiration date placeholders.*

FDA Label Image

Dorzolamide Container (Dorzolamide Container)

Label for Dorzolamide Hydrochloride 2% ophthalmic solution, USP, 10 mL, manufactured for Biocon Pharma Inc. The label indicates the active ingredient strength, usage instruction for eyes only, and manufacturing details including Biocon Pharma Inc. in New Jersey, USA, and Indoco Remedies Limited in Goa, India. It also includes dosage guidance to refer to product literature, and precautions to protect from light.*

FDA Label Image

123 (Structure)

Chemical structure of Dorzolamide Hydrochloride, showing its molecular arrangement including sulfonamide, sulfone, and thiazole functional groups along with the hydrochloride component.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.